Farrow Jeffrey S 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Farrow Jeffrey S
See Remarks
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-17−8,019→ 24,060 total→ Common Stock (8,019 underlying) - Exercise/Conversion
Common Stock
2025-03-15+8,019→ 26,155 total
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service.